Clinical Trial Update: Study to Evaluate Pharmacokinetic and Bioavailability of Envarsus® vs. Advagraf® in Liver Transplant Recipients [Phase 3]

View source ↗

Summary

A Phase 3 study comparing pharmacokinetics and bioavailability of Envarsus vs. Advagraf in liver transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Envarsus (tacrolimus)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Liver Transplantation | Phase 3 | Status: COMPLETED